Insider · CIK 0001007706
Josef H Von Rickenbach
Files at RNTX (Rein Therapeutics, Inc.). First filing May 28, 2026, latest May 28, 2026.
In brief
Josef H Von Rickenbach files SEC Form 4 as director at RNTX (Rein Therapeutics, Inc.). Since May 28, 2026, Josef H Von Rickenbach has reported 1 open-market buy worth $50k and 0 open-market sells worth $0, the latest filed on May 28, 2026.
A track record needs three past buys with six months of prices behind them; Josef H Von Rickenbach has 0, so none is measured yet.
The newest scored trade: bought $50k of RNTX on May 21, 2026, filed May 28, 2026, scored 50 (moderate). In the last 12 months: 1 buy worth $50k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RNTX: Rein Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | RNTXbuy Rein Therapeutics, Inc. | $50k 47,060 shares | +305% | +7% from low-49% from high |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | RNTX Rein Therapeutics, Inc. | POpen-market purchase Common stock , $0.001 par value | +3,420 | $1.04 | $3,564 | 18,874 | May 28, 2026 |
| May 22, 2026 | RNTX Rein Therapeutics, Inc. | POpen-market purchase Common stock , $0.001 par value | +15,950 | $1.05 | $17k | 34,824 | May 28, 2026 |
| May 26, 2026 | RNTX Rein Therapeutics, Inc. | POpen-market purchase Common stock , $0.001 par value | +23,190 | $1.06 | $24k | 58,014 | May 28, 2026 |
| May 27, 2026 | RNTX Rein Therapeutics, Inc. | POpen-market purchase Common stock , $0.001 par value | +4,500 | $1.07 | $4,819 | 62,514 | May 28, 2026 |
| Jul 23, 2025 | RNTX Rein Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +17,500 | $0.00 | $0 | 17,500 | Jul 23, 2025 |
| Dec 2, 2024 | RNTX Rein Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Dec 6, 2024 |
Questions about Josef H Von Rickenbach
Answered from the filings on this page, as of the latest one.
Is Josef H Von Rickenbach buying or selling?
In the last 12 months Josef H Von Rickenbach reported 1 open-market buy worth $50k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $50k of RNTX on May 21, 2026. Grants, option exercises and tax withholding are not counted.
How did Josef H Von Rickenbach's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Josef H Von Rickenbach has 0.
Where does Josef H Von Rickenbach file Form 4?
Josef H Von Rickenbach has filed Form 4 at RNTX (Rein Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.